Pediatric Hodgkin's disease: Current concepts in diagnosis and management

Indian Pediatrics

Volumn 37, Issue 9, 2000, Pages 933-938

  Kaicker, Shipra ^a   Kelly, Kara ^a,b  

^a Columbia University ^*  (United States)

^b Division of Medical Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE ANTIBIOTIC AGENT; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CHILDHOOD CANCER; CLINICAL TRIAL; DRUG INDUCED DISEASE; EDITORIAL; HEALTH CARE COST; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; PROGNOSIS; TUMOR BIOPSY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; COMBINED MODALITY THERAPY; FEMALE; HODGKIN DISEASE; HUMANS; INDIA; MALE; PROGNOSIS; RADIATION DOSAGE; RADIOTHERAPY; TREATMENT OUTCOME;

EID: 0033795807     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (33)

1. Hodgkin's lymphoma
2. Treatment of pediatric Hodgkin's lymphoma
3. Septicemia and meningitis in children splenectomized for Hodgkin's disease
4. Splenectomy and the increasing risk of secondary leukemia in Hodgkin's disease
5. Hodgkin's disease
6. Results of ultrasonic, computer tomography and clinical findings for the detection of abdominal involvement in Hodgkin's disease in childhood; A retrospective statistical analysis of 145 patients in the therapeutic study DAL-HD-82
7. Workshop report on Hodgkin's disease and related disease ('grey zone' lymphoma)
8. Pediatric Hodgkin's disease: Treatment in the late 1990's
9. Hodgkin's disease in Turkish Children: Clinical characteristics and treatment results of 210 children
10. Treatment results of Hodgkin's disease in Indian children
11. Application of theoretical models to chemotherapy protocol design
12. The balance between cure and late effects in childhood Hodgkin's lymphoma: The experience of the German-Austrian Study-Group since 1978-An overview
13. Breast cancer and other second neoplasms after childhood Hodgkin's disease
14. Late complications after Hodgkin's disease
15. Low dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: The experience of the French Society of Pediatric Oncology
16. Localized childhood Hodgkin's disease: Response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90
17. High cure rates and reduced long term toxicity in pediatric Hodgkin's disease: The German-Austrian Multicenter trial DAL-HD-90
18. Chemotherapy alone may be an efficient alternative in the treatment of early stage Hodgkin's disease if optimal radiotherapy is not available
19. Chemotherapy in Hodgkin's disease
20. Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group
21. Hodgkin's Disease
22. MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: Results of the Children's Cancer Group phase III trial
23. Randomized study of intensive MOPP-ABVD with or without low dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: A Pediatric Oncology Group Study
24. BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: Interim report from a trial of the German Hodgkin's Lymphoma Study Group
25. Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease
26. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma
27. Thallium-201 scintigraphy for assessment of a Gallium-67-avid mediastinal mass following therapy for Hodgkin's disease
28. Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease
29. Guidelines for cardiac monitoring of children during and after anthracycline therapy: Report of the Cardiology Committee of the Children's Cancer Study Group
30. A clinical review of Bleomycin - A new antineoplastic agent
31. Thyroid dysfunction after radiotherapy in children with Hodgkin's disease
32. Risk of secondary cancers after treatment for Hodgkin's disease
33. Breast carcinoma in women previously treated for Hodgkin's disease: Mammographic evaluation